Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at PLN 329.3B, ahead of Gilead Sciences (PLN 146.3B) and Biogen (PLN 44.9B). Figures as of 18 Nov 2026, 13:34 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenPLN 329.3B
Median
PLN 2.8B
Combined market value
PLN 3.41T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CarePLN 329.3BPLN 995.5BPLN 1,840.47 0.95% down 34% up United States
2Gilead SciencesGILD · Health CarePLN 146.3BPLN 848.8BPLN 684.29 1.60% up 33% up United States
3BiogenBIIB · Health CarePLN 44.9BPLN 149BPLN 1,007.95 0.34% down 49% up United States
4ModernaMRNA · Health CarePLN 14.8BPLN 336.3BPLN 831.15 3.93% down 755% up United States
5BioNTechBNTX · Health CarePLN 12.3BPLN 84.6BPLN 341.06 0.47% down 16% down Germany
6QiagenQGEN · Health CarePLN 10.1BPLN 41.3BPLN 199.95 0.12% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CarePLN 10BPLN 44BPLN 385.71 0.55% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CarePLN 5.5BPLN 67.5BPLN 666.85 0.37% up 20% up United States
9argenxARGX · Health CarePLN 5.5BPLN 239.5BPLN 3,808.18 0.36% down 4% up Belgium
10ImmunityBioIBRX · Health CarePLN 4BPLN 26.8BPLN 25.16 4.68% up 193% up United States
11RepligenRGEN · Health CarePLN 3.4BPLN 41.7BPLN 651.82 0.37% down 5% up United States
12Revolution MedicinesRVMD · Health CarePLN 2.9BPLN 141.4BPLN 653.87 2.50% down 131% up United States
13ExelixisEXEL · Health CarePLN 2.7BPLN 67.2BPLN 275.31 2.09% up 63% up United States
14Bio-TechneTECH · Health CarePLN 1.9BPLN 45.9BPLN 291.91 0.22% down 26% up United States
15CRISPR TherapeuticsCRSP · Health CarePLN 1.4BPLN 15.7BPLN 161.37 0.54% down 21% down Switzerland
16VaxcytePCVX · Health CarePLN 1.3BPLN 37.8BPLN 238.73 3.59% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CarePLN 1.2BPLN 18.5BPLN 114.50 2.22% up 88% up United States
18Kodiak SciencesKOD · Health CarePLN 780.3MPLN 25.4BPLN 389.05 3.90% down 396% up United States
19Twist BioscienceTWST · Health CarePLN 678.8MPLN 30.7BPLN 450.14 6.63% up 340% up United States
20Kymera TherapeuticsKYMR · Health CarePLN 655.7MPLN 41.7BPLN 488.40 3.44% down 87% up United States
21Scholar Rock HoldingSRRK · Health CarePLN 638.2MPLN 22.1BPLN 181.18 1.21% up 14% up United States
22Krystal BiotechKRYS · Health CarePLN 459.1MPLN 35.6BPLN 1,199.90 0.22% up 46% up United States
23ImmunovantIMVT · Health CarePLN 419.7MPLN 27.6BPLN 133.47 0.21% down 43% up United States
24CG OncologyCGON · Health CarePLN 156.7MPLN 28.3BPLN 317.27 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0191 PLN).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (PLN 329.3B), Gilead Sciences (PLN 146.3B) and Biogen (PLN 44.9B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 13:34 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of PLN 3.41T as of 18 Nov 2026, 13:34 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.